---
title: "First-in-human study of Cardiac Leaflet Enhancer reaches enrolment milestone"
date: "2025-10-22T13:49:02.000Z"
publishedDate: "22 octobre 2025"
summary: "Nyra Medical has announced the initiation of its first-in-human clinical study evaluating its novel Cardiac Leaflet Enhancer (CARLEN) system in patients with functional (secondary) mitral regurgitation (FMR). The study, focused on clinical safety and technical performance, has enrolled more than 10 patients, many with at least thirty-day follow-up to date."
importance: ""
sourceUrl: "https://cardiovascularnews.com/first-in-human-study-of-cardiac-leaflet-enhancer-reaches-enrolment-milestone/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2025-10-22-first-in-human-study-of-cardiac-leaflet-enhancer-reaches-enrolment-milestone"
imageUrl: "http://cardiovascularnews.com/wp-content/uploads/sites/14/2025/10/Nyra_Medical_Logo.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/first-in-human-study-of-cardiac-leaflet-enhancer-reaches-enrolment-milestone/"
---

![First-in-human study of Cardiac Leaflet Enhancer reaches enrolment milestone](http://cardiovascularnews.com/wp-content/uploads/sites/14/2025/10/Nyra_Medical_Logo.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/first-in-human-study-of-cardiac-leaflet-enhancer-reaches-enrolment-milestone/*

## L’essentiel

Nyra Medical has announced the initiation of its first-in-human clinical study evaluating its novel Cardiac Leaflet Enhancer (CARLEN) system in patients with functional (secondary) mitral regurgitation (FMR). The study, focused on clinical safety and technical performance, has enrolled more than 10 patients, many with at least thirty-day follow-up to date.

## Lien source

https://cardiovascularnews.com/first-in-human-study-of-cardiac-leaflet-enhancer-reaches-enrolment-milestone/
